In vitro fertilization in the polycystic ovary syndrome patient: an update.

作者信息

Lin Kathleen, Coutifaris Christos

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Clin Obstet Gynecol. 2007 Mar;50(1):268-76. doi: 10.1097/GRF.0b013e3180305fe4.

DOI:10.1097/GRF.0b013e3180305fe4

PMID:17304041

Abstract

摘要

相似文献

In vitro fertilization in the polycystic ovary syndrome patient: an update.

Clin Obstet Gynecol. 2007 Mar;50(1):268-76. doi: 10.1097/GRF.0b013e3180305fe4.

[Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].

Zhonghua Fu Chan Ke Za Zhi. 2006 Nov;41(11):740-4.

The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.

Saudi Med J. 2005 Oct;26(10):1584-7.

Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

Fertil Steril. 2005 Jun;83(6):1607-11. doi: 10.1016/j.fertnstert.2005.02.011.

Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports.

Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):239-40. doi: 10.1016/j.ejogrb.2011.03.002. Epub 2011 Apr 7.

Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.

Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25.

No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.

Fertil Steril. 2009 Apr;91(4 Suppl):1358-61. doi: 10.1016/j.fertnstert.2008.03.077. Epub 2008 Jun 13.

Treatment of polycystic ovary patients undergoing IVF.

J Assist Reprod Genet. 1997 Jan;14(1):10-2. doi: 10.1007/BF02765743.

Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome.

Fertil Steril. 2009 May;91(5):1755-9. doi: 10.1016/j.fertnstert.2008.02.009. Epub 2008 Apr 3.

[Evaluation of prophylactic approach to reduce incidence of ovarian hyperstimulation syndrome in in vitro fertilization].

Nihon Sanka Fujinka Gakkai Zasshi. 1995 Oct;47(10):1071-4.

引用本文的文献

Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

Hum Reprod Open. 2019 Jan 4;2019(1):hoy021. doi: 10.1093/hropen/hoy021. eCollection 2019.

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization.

Int J Fertil Steril. 2013 Jan;6(4):238-43. Epub 2013 Mar 3.

HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Drugs. 2008;68(13):1771-85. doi: 10.2165/00003495-200868130-00001.

Statins in the treatment of polycystic ovary syndrome.

Semin Reprod Med. 2008 Jan;26(1):127-38. doi: 10.1055/s-2007-992933.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验